PHOENIX, AZ--(Marketwired - May 22, 2014) - Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that Michael L. Babich, President and Chief Executive Officer, and Darryl Baker, Chief Financial Officer, will present at the following upcoming conferences:
- The Jefferies 2014 Global Healthcare Conference on June 2-5, 2014 at the Grand Hyatt in New York City. The presentation is scheduled for June 3, 2014 at 3:00 pm EDT.
- The 2014 Wells Fargo Securities Healthcare Conference on June 17-18, 2014 at the InterContinental Hotel in Boston. The presentation is scheduled for June 17, 2014 at 8:50 am EDT.
To listen to the audio webcast of these presentations, please visit: www.insysrx.com. A replay of this webcast will be available for 30 days after the initial presentation.
About Insys Therapeutics, Inc.
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative products for supportive care of cancer and pain patients. Using its proprietary sublingual spray technology and its capability to develop pharmaceutical cannabinoids, the company addresses the clinical shortcomings of existing commercial products. The company currently markets two products, Subsys, which is sublingual Fentanyl spray for break through cancer pain, and a generic version of Dronabinol (THC) capsules. The company plans to file a New Drug Application (NDA) for an oral liquid formulation of Dronabinol in the second half of 2014 and believes it is a clinically superior product to current Dronabinol capsules. The company is developing a robust pipeline of sublingual sprays, as well as pharmaceutical CBD.